These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 523534)

  • 1. Piracetam impairs the overshadowing of background stimuli by an informative CS.
    File SE; Hyde JR; Odling-Smee FJ
    Physiol Behav; 1979 Nov; 23(5):827-30. PubMed ID: 523534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of piracetam and of standardized ginseng extract on the electroconvulsive shock-induced memory disturbances in "step-down" passive avoidance.
    Lasarova MB; Mosharrof AH; Petkov VD; Markovska VL; Petkov VV
    Acta Physiol Pharmacol Bulg; 1987; 13(2):11-7. PubMed ID: 3673597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sodium oxybutyrate and piracetam acceleration of the compensatory-reparative processes after damage to the cerebral cortex in rats].
    Romanova GA; Trofimov SS
    Biull Eksp Biol Med; 1986 Dec; 102(12):661-3. PubMed ID: 3801613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of piracetam and gamma-aminobutyric acid on defensive conditioned reflexes in Xenopus laevis].
    Karulina OIu; Saakian SA
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1983; 33(1):166-7. PubMed ID: 6837151
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolongation of latencies for passive avoidance responses in rats treated with aniracetam or piracetam.
    Yamada K; Inoue T; Tanaka M; Furukawa T
    Pharmacol Biochem Behav; 1985 Apr; 22(4):645-8. PubMed ID: 3991773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of piracetam on pain sensitivity and levels of beta-endorphin in blood and cAMP in the cerebral cortex of rats].
    Vakulina OP; Iasnetsov VV; Isachenkov VA; Krylova IN; Tishkova IP; Bragin EO; Popkova EV
    Biull Eksp Biol Med; 1990 Feb; 109(2):163-5. PubMed ID: 2159815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of piracetam to facilitate acquisition or retention in younger or older rats.
    Means LW; Franklin RD; Cliett CE
    Exp Aging Res; 1980 Apr; 6(2):175-80. PubMed ID: 7389786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of piracetam on passive avoidance learning in ethanol-treated mice].
    Voigt JP; Fahl G; von Rottkay F; Morgenstern E
    Biomed Biochim Acta; 1986; 45(9):1191-4. PubMed ID: 3814108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative characteristics of the nootropic action of fenibut and fepiron].
    Kovaleva EL
    Farmakol Toksikol; 1984; 47(1):20-3. PubMed ID: 6705902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of piracetam and nicergoline on conditioned-reflex memory under conditions of extreme exposure].
    Pragina LL; Voronina TA; Inozemtsev AN; Kokaeva FF; Tushmalova NA
    Farmakol Toksikol; 1990; 53(3):8-10. PubMed ID: 2387387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Opposite changes in the integrating activity of the brain after treatment with piracetam and etimizol].
    Selivanova AT; Markova AE; Mutovkina LG; Potapenko EG
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1983; 33(1):157-9. PubMed ID: 6837149
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of oxiracetam on learning and memory in animals: comparison with piracetam.
    Mondadori C; Classen W; Borkowski J; Ducret T; Buerki H; Schadé A
    Clin Neuropharmacol; 1986; 9 Suppl 3():S27-38. PubMed ID: 3594453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The nootropic and anxiolytic properties of different doses of piracetam].
    Voronina TA; Molodavkin GM; Borlikova GG; Ostrovskaia RU; Tushmalova NA; Naznamov GG
    Eksp Klin Farmakol; 2000; 63(2):9-11. PubMed ID: 10834086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuropharmacological properties of piracetam derivatives].
    Ostrovskaia RU; Molodavkin GM; Trofimov SS; Popova RIa; Gudasheva TA
    Biull Eksp Biol Med; 1982 Dec; 94(12):62-5. PubMed ID: 6891272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A comparative study of the nootropic properties of piracetam and oxiracetam].
    Krylova IN; Antonova LV; Kamenskiĭ AA; Iasnetsov VV
    Farmakol Toksikol; 1991; 54(1):14-6. PubMed ID: 1860490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The memory-enhancing effects of the piracetam-like nootropics are dependent on experimental parameters.
    Mondadori C; Ducret T; Borkowski J
    Behav Brain Res; 1989 May; 33(1):79-82. PubMed ID: 2736062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral effects of piracetam in rats with isolation syndrome.
    Petkov VV; Rousseva S; Dimov S
    Acta Physiol Pharmacol Bulg; 1984; 10(3):3-9. PubMed ID: 6543288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of piracetam during prolonged use in an experiment].
    Rakhmankulova IKh; Garibova TL; Voronin KE; Tilekeeva UM; Voronina TA
    Farmakol Toksikol; 1985; 48(4):42-6. PubMed ID: 4043362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Piracetam correction of deficient GABA-ergic inhibition due to early postnatal exposure to cycloheximide].
    Burov IuV; Ostrovskaia RU; Smol'nikova NM; Trofimov SS; Molodavkin GM
    Biull Eksp Biol Med; 1986 Apr; 101(4):447-9. PubMed ID: 3008881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facilitating effect of oxiracetam and piracetam on acquisition of discrete two-way shuttle avoidance in normal mice.
    Kuribara H; Tadokoro S
    Jpn J Pharmacol; 1988 Dec; 48(4):494-8. PubMed ID: 3244203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.